Staar Results 2024 Expectations. 5% net sales increase to $77.4m, 9% icl sales growth. Net sales were $77.4 million for the first quarter of 2024, up 5% compared to $73.5 million reported in the prior year quarter.
The medical instruments supplier reported ($0.07) eps for. Window opening date closing date content area;
Window Opening Date Closing Date Content Area;
Gross margin at 78.9%, but $3.3m net loss.
Net Sales Were $77.4 Million For The First Quarter Of 2024, Up 5% Compared To $73.5 Million Reported In The Prior Year Quarter.
Eps of $0.11 beats by $0.05 | revenue of $77.36m (5.21% y/y) beats by $1.41m.
Staar Is The State's Testing Program And Is Based On State Curriculum Standards In Core Subjects Including Rla, Mathematics, Science, And Social Studies.
Images References :
Expectations For Students / Parents;.
Earnings per share (eps) also surpassed analyst.
Net Sales Were $77.4 Million For The First Quarter Of 2024, Up 5% Compared To $73.5 Million Reported In The Prior Year Quarter.
First quarter 2024 financial results.
Staar Surgical Revenues And Earnings Beat Expectations.